Possibilities for an extended classification of bladder cancer

Area of Science:

• Urology
• Oncology
• Medical Diagnostics

Background:

• Bladder cancer prognosis relies on various clinical and pathological factors.
• Predictive models for bladder cancer require robust validation.
• Urinary carcinoembryonic antigen (U-CEA) shows potential as a non-invasive biomarker.

Purpose of the Study:

• To assess the combined prognostic value of T-class, histopathological grade, and U-CEA in bladder cancer.
• To evaluate the predictive capability of a composite scoring system for patient survival.
• To explore the utility of pre-treatment variables and post-treatment cytology in predicting bladder cancer outcomes.

Main Methods:

• Patients with bladder cancer were assessed for T-class, grade, and U-CEA pre-treatment.
• A scoring system was developed by summing dichotomized clinical and pathological variables.
• Life-table analysis and log-rank tests were employed to evaluate prognostic trends.

Main Results:

• A combined score integrating T-class, grade, and U-CEA demonstrated significant prognostic value.
• Patients with higher composite scores showed significantly better symptom-free survival (p=0.0019).
• Higher scores were also associated with improved relative survival rates (p=0.0005).

Conclusions:

• A combination of pre-treatment variables (T-class, grade, U-CEA) offers significant predictive value for bladder cancer.
• The developed scoring system can aid in stratifying patients for prognostic assessment.
• This multi-variable approach enhances the prediction of survival outcomes in bladder cancer management.